{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:55:04Z","timestamp":1791273304777,"version":"4.1.0"},"reference-count":14,"publisher":"Wiley","issue":"9","license":[{"start":{"date-parts":[[2026,9,6]],"date-time":"2026-09-06T00:00:00Z","timestamp":1788652800000},"content-version":"vor","delay-in-days":5,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clinical Case Reports"],"published-print":{"date-parts":[[2026,9]]},"abstract":"<jats:title>ABSTRACT<\/jats:title>\n                  <jats:p>Carefully selected elderly patients with metastatic PSCC may obtain a durable complete response via tislelizumab chemoimmunotherapy combined with metformin and standardized MDT management, providing practical clinical reference for high\u2010risk elderly lung cancer patients complicated with multiple comorbidities.<\/jats:p>","DOI":"10.1002\/ccr3.73481","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T03:41:00Z","timestamp":1788752460000},"update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Complete Response to Tislelizumab in an Elderly Patient With Metastatic Pulmonary Squamous Cell Carcinoma: Potential Synergy With Metformin and Multidisciplinary Management"],"prefix":"10.1002","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1037-2409","authenticated-orcid":false,"given":"Lei","family":"Li","sequence":"first","affiliation":[{"name":"Cancer Hospital of Shantou University Medical College  Shantou Guangdong China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2026,9,6]]},"reference":[{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21660"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1001\/jamaoncol.2021.0366"},{"issue":"5","key":"e_1_2_12_4_1","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1470-2045(23)00108-0","article-title":"Tislelizumab Plus Chemotherapy Versus Chemotherapy Alone as First\u2010Line Treatment for Advanced Squamous Non\u2010Small\u2010Cell Lung Cancer","volume":"24","author":"RATIONALE\u2010307 Investigators","year":"2023","journal-title":"Lancet Oncology"},{"issue":"1","key":"e_1_2_12_5_1","article-title":"Metformin as an Archetype Immuno\u2010Metabolic Adjuvant for Cancer Immunotherapy","volume":"11","author":"Verdura S.","year":"2022","journal-title":"Oncoimmunology"},{"key":"e_1_2_12_6_1","first-page":"102","article-title":"The Role of the Multidisciplinary Team in the Management of Advanced Lung Cancer: A Consensus Statement","volume":"159","author":"Bachelot T.","year":"2021","journal-title":"Lung Cancer"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtho.2015.09.009"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1801946"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2018.07.030"},{"key":"e_1_2_12_10_1","article-title":"Are Metformin\u2010Based Combination Approaches Beneficial for Non\u2010Small Cell Lung Cancer: Evidence From Experimental and Clinical Studies","volume":"13","author":"Thyagarajan A.","year":"2023","journal-title":"Frontiers in Oncology"},{"issue":"3","key":"e_1_2_12_11_1","article-title":"Clinical Outcomes in Non\u2010Small\u2010Cell Lung Cancer Patients Receiving Concurrent Metformin and Immune Checkpoint Inhibitors","volume":"8","author":"Afzal M.","year":"2019","journal-title":"Lung Cancer Management"},{"issue":"10","key":"e_1_2_12_12_1","first-page":"2169","article-title":"Overcoming Acquired Resistance to PD\u20101 Inhibitor With the Addition of Metformin in Small Cell Lung Cancer (SCLC)","volume":"69","author":"Kim Y.","year":"2020","journal-title":"Cancer Immunology, Immunotherapy"},{"issue":"17","key":"e_1_2_12_13_1","first-page":"2013","article-title":"Management of Immune\u2010Related Adverse Events in Patients Treated With Immune Checkpoint Inhibitor Therapy: ASCO Guideline Update","volume":"42","author":"Schneider B. J.","year":"2024","journal-title":"Journal of Clinical Oncology"},{"issue":"7","key":"e_1_2_12_14_1","first-page":"1003","article-title":"Addressing the Quality of Life Needs of Older Patients With Cancer: A Position Paper From the International Society of Geriatric Oncology (SIOG)","volume":"12","author":"Scotte F.","year":"2021","journal-title":"Journal of Geriatric Oncology"},{"issue":"2","key":"e_1_2_12_15_1","first-page":"201","article-title":"Immunotherapy in Older Patients With Non\u2010Small Cell Lung Cancer: Young International Society of Geriatric Oncology Position Paper","volume":"15","author":"Gomes F.","year":"2020","journal-title":"Journal of Thoracic Oncology"}],"container-title":["Clinical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.73481","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/ccr3.73481","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/ccr3.73481","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T07:40:08Z","timestamp":1791272408000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/ccr3.73481"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["10.1002\/ccr3.73481"],"URL":"https:\/\/doi.org\/10.1002\/ccr3.73481","archive":["Portico"],"relation":{},"ISSN":["2050-0904","2050-0904"],"issn-type":[{"value":"2050-0904","type":"print"},{"value":"2050-0904","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"2026-02-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-08-27","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-09-06","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}],"article-number":"e73481"}}